Indian pharma sector to grow at 10-12 pc during FY19-22, says ICRA Medical Dialogues Bureau19 Dec 2019 10:00 AM ISTIcra, however, warned that while the US growth is expected to remain at high single-digit to low double-digit, it will face headwinds given the...
Astellas, Seattle Genetics cancer drug Padcev gets speedy nod from USFDA Medical Dialogues Bureau19 Dec 2019 9:30 AM ISTThe drug, Padcev, is the first USFDA approved treatment in the United States for patients with advanced or metastatic urothelial cancer, Astellas...
Biohaven Pharma acute migraine drug Vazegepant succeeds in study Medical Dialogues Bureau19 Dec 2019 9:15 AM ISTVazegepant is the first CGRP treatment delivered in an intranasal formulation, which benefits patients uncomfortable with needles, Biohaven Pharma...
Purdue Pharma CEO bonus opposed by senators Medical Dialogues Bureau19 Dec 2019 8:59 AM IST"Purdue Pharma is still more concerned with motivating high-level employees to sell more drugs than it is with public health or helping states...
Hetero launches HIV drug Taffic in India post DCGI nod Medical Dialogues Bureau18 Dec 2019 11:30 AM ISTHetero Lab's antiretroviral combination drug- Taffic is a generic version of Gilead's Biktarvy and has been approved by the Drug Controller General of...
Lupin arm Nanomi BV completes Kyowa divestiture to Unison Medical Dialogues Bureau18 Dec 2019 9:45 AM IST"The transaction generates post-tax net cash inflow of nearly 33,429 million Japanese yen (about Rs 2,158 crore) and significantly strengthens Lupin's...
GSK seeks USFDA nod for myeloma drug Belantamab Mafodotin Medical Dialogues Bureau18 Dec 2019 9:25 AM ISTThe trial was testing GSK's experimental multiple myeloma drug Belantamab Mafodotin, also known as GSK2857916, in patients who had received four to...
Sanofi Allegra shows positive results in phase 3 study for allergic rhinitis Farhat Nasim18 Dec 2019 9:15 AM IST"The study demonstrated that Allegra/Telfast 180mg significantly decreased pollution- exacerbated AR symptoms by 21% (p=0.0148) in adult allergic...
Bayer appeals to reverse USD 25 million Roundup verdict Medical Dialogues Bureau18 Dec 2019 9:00 AM ISTIn a filing in the U.S. Court of Appeals for the 9th Circuit dated Friday, Bayer said the verdict defied regulatory findings and sound science, adding...
Indian trademark rights, brand for anti-diabetic drug Vildagliptin acquired by Cipla Medical Dialogues Bureau17 Dec 2019 2:14 PM ISTCipla has been co-marketing Vildagliptin in agreement with Novartis under brand names Vysov and Vysov M (Vildagliptin plus Metformin), the company...
Indoco Remedies Goa plant gets GMP certificate from UK health regulator Medical Dialogues Bureau17 Dec 2019 9:30 AM ISTThis is an outcome of the last successful inspection conducted by UK Medicines and Healthcare Products Regulatory Agency (MHRA) from September 16-20...
Pfizer, Astellas Pharma get USFDA nod for prostate cancer therapy Xtandi Medical Dialogues Bureau17 Dec 2019 9:15 AM ISTPfizer said Xtandi, in combination with an anti-hormone therapy, reduced the risk of cancer spreading or deaths by 61% in men with the disease,...
